RK 20448-Trihydrochloride is a relative of A 419259 Trihydrochloride (A101040), which is the hydrochloride form of A 419259, a Src kinase inhibitor and can be used in treatment of chronic myelogenous leukemia, lymphangioleiomyomatosis and tuberous sclerosis.